Cite
HARVARD Citation
Vergote, I. et al. (2010). Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer. International journal of gynecological cancer. 20 (5), pp. 772-780. [Online].